Meet the founder

Shahram Seyedin-Noor
Founder | General Partner


Shahram is Founder and General Partner at Civilization Ventures, a venture capital firm focused on supporting cutting edge innovations in health tech and biology.

Prior to founding Civilization Ventures, Shahram was an entrepreneur and angel investor. Shahram is a founding executive in several life sciences companies, including Rgenix, a biotech company with first-in-class therapeutics for cancer, now in Phase 1 clinical trials. Prior to Rgenix, he was founding CFO and VP of Corporate Development at NextBio, a genomics big data analytics pioneer acquired by Illumina in 2013. Shahram is also a seed investor in pioneering startups such as Omada Health, Counsyl (acq. by Myriad), Bina (acq. by Roche) and Avantome (acq. by Illumina).

Shahram began his career in Silicon Valley as startup counsel at Wilson Sonsini Goodrich & Rosati, and later as a high tech investment banker at Goldman Sachs. Shahram earned his JD from Harvard Law School, where he was elected Editor-in-Chief of the Harvard International Law Journal, and obtained a BA in Economics from Pomona College.


Meet the team

Themasap Khan, PhD Candidate
Stanford School of Medicine

Themasap is an associate at Civilization Ventures and PhD candidate at Stanford University studying stem cell biology, regenerative medicine and neuroscience. His work involves using state-of-the-art stem cell biology, genome engineering, live imaging and neurobiology approaches with high-throughput in-vitro assays to identify dynamic processes that are altered in cells derived from patients with psychiatric diseases to find targets for therapeutics. Prior to Civilization Ventures, Themasap consulted for CRV, Menlo Ventures and McKinsey & Co, and he started a tutoring business which is still thriving. Themasap obtained his B.S. in Neuroscience with a minor in Finance from NYU.

Sonya Iverson, PhD
Boston University

Sonya is a research scientist developing novel gene therapies at Sana Biotechnology. She earned her PhD at Boston University where she studied synthetic biology, molecular biology, and computer-aided bio-design, with a focus on methods for streamlined genetic engineering using library-based DNA assembly. Sonya developed the first multipart DNA assembly standard and library for use in bacteria, a kit which is publicly available and still widely used. After earning her B.S. in Biotechnology with a minor in Genetics at Montana State University, Sonya started a non-profit organization for refugee youth in the U.S. and Lebanon which she still runs.

Advisors Graphic
Network of Advisors
PhD, MD, CEO Advisors

Network of Advisors

Civilization Ventures leverages an extensive network of world-class scientists and clinicians (including half a dozen MDs and PhDs), as well as accomplished founders and CEOs from our portfolio companies, to gain access to and understand the leading innovations in our space. Our network is truly global, with key advisors located in Silicon Valley, Cambridge and NY in the US, as well as Europe and Asia.

Our international reach and deep domain expertise has empowered us to invest in exponential health technologies and synthetic biology companies worldwide, with founders who have earned advanced degrees from leading academic institutions such as Harvard, MIT, Stanford, Columbia, Oxford, Cambridge, Caltech, UBC, OHSU and beyond. Our core mission is to back truly disruptive innovation that has the potential to advance our civilization.